| R-HSA-109582 |
Hemostasis |
| R-HSA-111885 |
Opioid Signalling |
| R-HSA-113501 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| R-HSA-113510 |
E2F mediated regulation of DNA replication |
| R-HSA-1257604 |
PIP3 activates AKT signaling |
| R-HSA-1280215 |
Cytokine Signaling in Immune system |
| R-HSA-1280218 |
Adaptive Immune System |
| R-HSA-1295596 |
Spry regulation of FGF signaling |
| R-HSA-141424 |
Amplification of signal from the kinetochores |
| R-HSA-141444 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
| R-HSA-1430728 |
Metabolism |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-162582 |
Signal Transduction |
| R-HSA-163685 |
Integration of energy metabolism |
| R-HSA-163767 |
PP2A-mediated dephosphorylation of key metabolic factors |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1640170 |
Cell Cycle |
| R-HSA-1643685 |
Disease |
| R-HSA-166016 |
Toll Like Receptor 4 (TLR4) Cascade |
| R-HSA-166058 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane |
| R-HSA-166166 |
MyD88-independent TLR4 cascade |
| R-HSA-166520 |
Signaling by NTRKs |
| R-HSA-168138 |
Toll Like Receptor 9 (TLR9) Cascade |
| R-HSA-168142 |
Toll Like Receptor 10 (TLR10) Cascade |
| R-HSA-168164 |
Toll Like Receptor 3 (TLR3) Cascade |
| R-HSA-168176 |
Toll Like Receptor 5 (TLR5) Cascade |
| R-HSA-168179 |
Toll Like Receptor TLR1:TLR2 Cascade |
| R-HSA-168181 |
Toll Like Receptor 7/8 (TLR7/8) Cascade |
| R-HSA-168188 |
Toll Like Receptor TLR6:TLR2 Cascade |
| R-HSA-168249 |
Innate Immune System |
| R-HSA-168256 |
Immune System |
| R-HSA-168898 |
Toll-like Receptor Cascades |
| R-HSA-180024 |
DARPP-32 events |
| R-HSA-181438 |
Toll Like Receptor 2 (TLR2) Cascade |
| R-HSA-187037 |
Signaling by NTRK1 (TRKA) |
| R-HSA-190236 |
Signaling by FGFR |
| R-HSA-194315 |
Signaling by Rho GTPases |
| R-HSA-195253 |
Degradation of beta-catenin by the destruction complex |
| R-HSA-195258 |
RHO GTPase Effectors |
| R-HSA-195721 |
Signaling by WNT |
| R-HSA-195721 |
Signaling by WNT |
| R-HSA-196299 |
Beta-catenin phosphorylation cascade |
| R-HSA-198725 |
Nuclear Events (kinase and transcription factor activation) |
| R-HSA-198753 |
ERK/MAPK targets |
| R-HSA-199418 |
Negative regulation of the PI3K/AKT network |
| R-HSA-201681 |
TCF dependent signaling in response to WNT |
| R-HSA-201681 |
TCF dependent signaling in response to WNT |
| R-HSA-202670 |
ERKs are inactivated |
| R-HSA-212436 |
Generic Transcription Pathway |
| R-HSA-2465910 |
MASTL Facilitates Mitotic Progression |
| R-HSA-2467813 |
Separation of Sister Chromatids |
| R-HSA-2500257 |
Resolution of Sister Chromatid Cohesion |
| R-HSA-2555396 |
Mitotic Metaphase and Anaphase |
| R-HSA-3700989 |
Transcriptional Regulation by TP53 |
| R-HSA-372790 |
Signaling by GPCR |
| R-HSA-388396 |
GPCR downstream signalling |
| R-HSA-388841 |
Costimulation by the CD28 family |
| R-HSA-389513 |
CTLA4 inhibitory signaling |
| R-HSA-418346 |
Platelet homeostasis |
| R-HSA-418594 |
G alpha (i) signalling events |
| R-HSA-432142 |
Platelet sensitization by LDL |
| R-HSA-448424 |
Interleukin-17 signaling |
| R-HSA-449147 |
Signaling by Interleukins |
| R-HSA-450282 |
MAPK targets/ Nuclear events mediated by MAP kinases |
| R-HSA-450294 |
MAP kinase activation |
| R-HSA-453274 |
Mitotic G2-G2/M phases |
| R-HSA-453279 |
Mitotic G1 phase and G1/S transition |
| R-HSA-4641262 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane |
| R-HSA-4641262 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane |
| R-HSA-4791275 |
Signaling by WNT in cancer |
| R-HSA-4839735 |
AXIN mutants destabilize the destruction complex, activating WNT signaling |
| R-HSA-4839743 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex |
| R-HSA-4839744 |
truncated APC mutants destabilize the destruction complex |
| R-HSA-4839748 |
AMER1 mutants destabilize the destruction complex |
| R-HSA-5339716 |
Misspliced GSK3beta mutants stabilize beta-catenin |
| R-HSA-5358747 |
S33 mutants of beta-catenin aren't phosphorylated |
| R-HSA-5358749 |
S37 mutants of beta-catenin aren't phosphorylated |
| R-HSA-5358751 |
S45 mutants of beta-catenin aren't phosphorylated |
| R-HSA-5358752 |
T41 mutants of beta-catenin aren't phosphorylated |
| R-HSA-5467337 |
APC truncation mutants have impaired AXIN binding |
| R-HSA-5467340 |
AXIN missense mutants destabilize the destruction complex |
| R-HSA-5467348 |
Truncations of AMER1 destabilize the destruction complex |
| R-HSA-5633007 |
Regulation of TP53 Activity |
| R-HSA-5654726 |
Negative regulation of FGFR1 signaling |
| R-HSA-5654727 |
Negative regulation of FGFR2 signaling |
| R-HSA-5654732 |
Negative regulation of FGFR3 signaling |
| R-HSA-5654733 |
Negative regulation of FGFR4 signaling |
| R-HSA-5654736 |
Signaling by FGFR1 |
| R-HSA-5654738 |
Signaling by FGFR2 |
| R-HSA-5654741 |
Signaling by FGFR3 |
| R-HSA-5654743 |
Signaling by FGFR4 |
| R-HSA-5663202 |
Diseases of signal transduction by growth factor receptors and second messengers |
| R-HSA-5663220 |
RHO GTPases Activate Formins |
| R-HSA-5673000 |
RAF activation |
| R-HSA-5673001 |
RAF/MAP kinase cascade |
| R-HSA-5675221 |
Negative regulation of MAPK pathway |
| R-HSA-5683057 |
MAPK family signaling cascades |
| R-HSA-5684996 |
MAPK1/MAPK3 signaling |
| R-HSA-6804757 |
Regulation of TP53 Degradation |
| R-HSA-6806003 |
Regulation of TP53 Expression and Degradation |
| R-HSA-6811558 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling |
| R-HSA-68875 |
Mitotic Prophase |
| R-HSA-68877 |
Mitotic Prometaphase |
| R-HSA-68882 |
Mitotic Anaphase |
| R-HSA-68886 |
M Phase |
| R-HSA-68886 |
M Phase |
| R-HSA-69206 |
G1/S Transition |
| R-HSA-69231 |
Cyclin D associated events in G1 |
| R-HSA-69236 |
G1 Phase |
| R-HSA-69273 |
Cyclin A/B1/B2 associated events during G2/M transition |
| R-HSA-69275 |
G2/M Transition |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69278 |
Cell Cycle, Mitotic |
| R-HSA-69618 |
Mitotic Spindle Checkpoint |
| R-HSA-69620 |
Cell Cycle Checkpoints |
| R-HSA-70171 |
Glycolysis |
| R-HSA-70326 |
Glucose metabolism |
| R-HSA-71387 |
Metabolism of carbohydrates |
| R-HSA-73857 |
RNA Polymerase II Transcription |
| R-HSA-74160 |
Gene expression (Transcription) |
| R-HSA-9006925 |
Intracellular signaling by second messengers |
| R-HSA-9006934 |
Signaling by Receptor Tyrosine Kinases |
| R-HSA-937061 |
TRIF(TICAM1)-mediated TLR4 signaling |
| R-HSA-9607240 |
FLT3 Signaling |
| R-HSA-9634600 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism |
| R-HSA-9648025 |
EML4 and NUDC in mitotic spindle formation |
| R-HSA-975138 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation |
| R-HSA-975155 |
MyD88 dependent cascade initiated on endosome |
| R-HSA-975871 |
MyD88 cascade initiated on plasma membrane |
